MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s40292-023-00615-z

Медицинская библиотека · High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023

Efficacy of Allopurinol in Improving Endothelial Dysfunction: A Systematic Review and Meta-Analysis.

Qazi Shurjeel Uddin, Qamar Usama, Maqsood Muhammad Talha, Gul Rabbia, Ansari Saad Ali, Imtiaz Zeeshan, Noor Amatul, Suheb Mahammed Zia Khan, Zaheer Zaofashan, Andleeb Adeela, Naseem Masooma, Akram Muhammad Shariq, Ali Mubarak, Barmanwalla Alina, Tareen Rutab, Zaheer Irfa

МетаанализСистематический обзорСтатьяПеревод в очереди

Аннотация

INTRODUCTION

Endothelial dysfunction has been implicated in various cardiovascular disorders as the initial pathology. Allopurinol has been shown to improve endothelial dysfunction in patients with gout, but its effect on cardiovascular patients is unclear.

AIMS: We aim to assess allopurinol efficacy in improving endothelial dysfunction overall and in different disease states including but not limited to heart failure, chronic kidney disease, ischemic heart disease

METHODS

We conducted a literature search of PubMed, Cochrane's Central Library, and Scopus until December 2022, including randomized controlled trials and double-arm observational studies. The primary outcome measure was endothelial function assessed by change in flow mediated dilation (FMD)

RESULTS

Our meta-analysis included 22 studies with a total of 1472 patients. Our pooled analysis shows that allopurinol significantly improved FMD (WMD = 1.46%, 95% CI [0.70, 2.22], p < 0.01) compared to control. However, there was no significant difference between allopurinol and control for endothelial-independent vasodilation measured by forearm blood flow (WMD = 0.10%, 95% CI [- 0.89, 0.69], p = 0.80). Subgroup analysis indicated that the effect of allopurinol on FMD was more significant in diabetic and congestive heart failure patients.

CONCLUSION

While allopurinol may improve endothelial function in various patient populations, further high-quality randomized controlled trials are needed to determine its efficacy in preventing cardiovascular disease exacerbation.

Для цитирования: Qazi Shurjeel Uddin, Qamar Usama, Maqsood Muhammad Talha, Gul Rabbia, Ansari Saad Ali, Imtiaz Zeeshan, Noor Amatul, Suheb Mahammed Zia Khan, Zaheer Zaofashan, Andleeb Adeela, Naseem Masooma, Akram Muhammad Shariq, Ali Mubarak, Barmanwalla Alina, Tareen Rutab, Zaheer Irfa. Efficacy of Allopurinol in Improving Endothelial Dysfunction: A Systematic Review and Meta-Analysis.. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2023. DOI: 10.1007/s40292-023-00615-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.